Drug Type Small molecule drug |
Synonyms Dual A2AR/A2BR antagonists(Fudan University), Compound 7aj |
Target |
Action antagonists |
Mechanism A2aR antagonists(Adenosine A2a receptor antagonists), A2bR antagonists(Adenosine A2b receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | China | 14 Mar 2024 |